Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EW0P | ISIN: US00808Y4061 | Ticker-Symbol: EJU0
Lang & Schwarz
06.06.25 | 07:00
0,430 Euro
-100,00 % -0,430
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
AETHLON MEDICAL INC Chart 1 Jahr
5-Tage-Chart
AETHLON MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,4200,44006.06.

Aktuelle News zur AETHLON MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrXFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 06.06.2025313The following instruments on Boerse Frankfurt do have their last trading day on 06.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 06.06.2025ISIN NameDE0005227201 BIOTEST...
► Artikel lesen
FrXFRA ISIN CHANGE199Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS0977021049 Bolt Biotherapeutics Inc. 06.06.2025 US0977022039 Bolt Biotherapeutics Inc. 09.06.2025 Tausch 20:1SE0018041097 Spotr...
► Artikel lesen
DoAETHLON MEDICAL INC - 8-K, Current Report2
13.05.AETHLON MEDICAL INC - 8-K, Current Report2
17.03.AETHLON MEDICAL INC - 8-K, Current Report4
24.02.XFRA DIVERSE INSTRUMENTE: AUSSETZUNG/SUSPENSION1.329DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCASTOR MARITIME...
► Artikel lesen
13.02.Aethlon Medical strengthens oncology trial with protocol updates and cost reductions4
AETHLON MEDICAL Aktie jetzt für 0€ handeln
12.02.AETHLON MEDICAL INC - 10-Q, Quarterly Report-
12.02.AETHLON MEDICAL INC - 8-K, Current Report-
08.01.AETHLON MEDICAL INC - 8-K, Current Report13
20.12.24AETHLON MEDICAL INC - 8-K, Current Report18
13.11.24Aethlon Medical, Inc.: Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update146Achieves Key Milestone with Enrollment of First Two Patients in the Safety, Feasibility, and Dose Finding Study of Aethlon's Hemopurifier® in Patients with Solid...
► Artikel lesen
11.11.24Aethlon Medical, Inc.: Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier Cancer Trial in Australia216Patient Enrolled at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital Aethlon's Trial is a Safety, Feasibility, and Dose Finding Study of the Hemopurifier®...
► Artikel lesen
14.08.24Aethlon Medical, Inc.: Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update202Received Two Australian Ethics Committee Approvals for a Safety, Feasibility, and Dose Finding Study of Aethlon's Hemopurifier® in Patients with Solid Tumors Not Responding to Anti-PD-1 Antibodies...
► Artikel lesen
12.08.24Aethlon Medical, Inc.: Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier Cancer Trial319Bellberry Human Research Ethics Committee Granted Full Ethics Approval to the Pindara Private Hospital for a Safety, Feasibility, and Dose Finding Study of Aethlon's Hemopurifier® in Patients with...
► Artikel lesen
27.06.24Aethlon Medical, Inc.: Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update272Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO, June 27, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1